MedPath

Hypothermia and Hemostasis After Cardiac Arrest

Not Applicable
Conditions
Hypothermia
Heart Arrest
Hemostasis
Coagulants
Interventions
Other: Therapeutic hypothermia
Registration Number
NCT02258360
Lead Sponsor
University of Aarhus
Brief Summary

This is a sub-study to the Time-differentiated Therapeutic Hypothermia (TTH48, ClinicalTrials.gov Identifier: NCT01689077). TTH48 compares 24 with 48 hours of therapeutic hypothermia at a target temperature of 32-34°C in survivors of out-of-hospital cardiac arrest.

The overall aim of this sub-study is to examine the hemostasis in patients resuscitated after cardiac arrest and treated with 24 and 48 hours of therapeutic hypothermia

Our specific aims are:

* To investigate the whole blood coagulation using the rotational thromboelastometry.

* To investigate the function of platelets

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
82
Inclusion Criteria
  • Out of hospital cardiac arrest of presumed cardiac cause
  • Return of spontaneous circulation (ROSC)
  • Glasgow Coma Score < 8
  • Age > 18 years and < 80 years
Read More
Exclusion Criteria
  • > 60 minutes from the circulatory collapse to ROSC
  • Time interval > 4 hours from cardiac arrest to initiation of therapeutic hypothermia
  • Terminal illness
  • Coagulation disorder
  • Unwitnessed asystolia
  • Cerebral performance category 3-4 before the cardiac arrest
  • Severe persistent cardiogenic shock
  • Pregnancy
  • Persistent cardiogenic shock (systolic blood pressure < 80 despite inotropic treatment)
  • New apoplexy or intracerebral hemorrhage
  • Lack of consent from the relatives
  • Lack of consent from the GP
  • Lack of consent from the patient if he/she wakes up and is relevant
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
24 hours hypothermiaTherapeutic hypothermiaTherapeutic hypothermia for 24 hours after reaching target temperature
48 hours hypothermiaTherapeutic hypothermiaTherapeutic hypothermia for 48 hours after reaching target temperature
Primary Outcome Measures
NameTimeMethod
Clotting time in seconds, EXTEMAfter 46 hours

Measured by thomboelastometry on the ROTEM®

Area under the curve, COL-testAfter 46 hours

Platelet function will be measured using Multiplate®

Secondary Outcome Measures
NameTimeMethod
Clot formation time in seconds, -EXTEM, INTEM, FIBTEM and HEPTEMAfter 22 hours, 46 hours and 70 hours

Measured by thomboelastometry on the ROTEM®.

Maximum clot firmness (mm), -EXTEM, INTEM, FIBTEM and HEPTEMAfter 22 hours, 46 hours and 70 hours

Measured by thomboelastometry on the ROTEM®.

Area under the curve, COL-testAfter 22 hours and 70 hours

Platelet function will be measured using Multiplate®.

Clotting time in seconds, EXTEMAfter 22 hours and 70 hours

Measured by thomboelastometry on the ROTEM®.

Clotting time in seconds, -INTEM, FIBTEM and HEPTEMAfter 22 hours, 46 hours and 70 hours

Measured by thomboelastometry on the ROTEM®.

Maximum velocity (mm/min), -EXTEM, INTEM, FIBTEM and HEPTEMAfter 22 hours, 46 hours and 70 hours

Measured by thomboelastometry on the ROTEM®.

Area under the curve, Thrombin generationAfter 22 hours, 46 hours and 70 hours
Area under the curve,- ADP, ASPI and TRAP-test.After 22 hours, 46 hours and 70 hours

Platelet function will be measured using Multiplate®.

Time to maximum velocity (s), -EXTEM, INTEM, FIBTEM and HEPTEMAfter 22 hours, 46 hours and 70 hours

Measured by thomboelastometry on the ROTEM®.

Area under the curve, Clot stability testAfter 22 hours, 46 hours and 70 hours

Trial Locations

Locations (1)

Dept of Anesthesiology and Intensive Care and Dept of Clinical Biochemistry, Aarhus University Hospital, Skejby

🇩🇰

Aarhus, Aarhus N, Denmark

© Copyright 2025. All Rights Reserved by MedPath